SORT LNP

BASEL, Switzerland, May 21, 2026 Novartis announced it will present more than 65 company-sponsored and investigator-sponsored abstracts at the...

MENLO PARK, California, May 20, 2026 ReCode Therapeutics announced positive clinical data from its RCT1100 inhaled mRNA therapy program...